Cargando…
Early in vivo signaling profiles in MUC1-specific CD4(+) T cells responding to two different MUC1-targeting vaccines in two different microenvironments
Vaccines are beginning to be explored for as measures to prevent cancer. Since determining the efficacy of vaccines by evaluating disease outcome requires a long time, there is an urgent need for early predictive biomarkers. To this end, immunological endpoints that can be assessed weeks or months p...
Autores principales: | Reichenbach, Dawn K., Finn, Olivera J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661169/ https://www.ncbi.nlm.nih.gov/pubmed/23802084 http://dx.doi.org/10.4161/onci.23429 |
Ejemplares similares
-
MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016) -
Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)
por: Buyuk, Melek, et al.
Publicado: (2023) -
Complex of MUC1, CIN85 and Cbl in Colon Cancer Progression and Metastasis
por: Cascio, Sandra, et al.
Publicado: (2015) -
Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
por: Kim, Su-Mi, et al.
Publicado: (2012) -
Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
por: Fang, Jun, et al.
Publicado: (2023)